Cargando…
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
Despite the continuous advancement in neurosciences as well as in the knowledge of human behaviors pathophysiology, currently suicide represents a puzzling challenge. The World Health Organization (WHO) has established that one million people die by suicide every year, with the impressive daily rate...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213585/ https://www.ncbi.nlm.nih.gov/pubmed/30249029 http://dx.doi.org/10.3390/ijms19102888 |
_version_ | 1783367805651910656 |
---|---|
author | De Berardis, Domenico Fornaro, Michele Valchera, Alessandro Cavuto, Marilde Perna, Giampaolo Di Nicola, Marco Serafini, Gianluca Carano, Alessandro Pompili, Maurizio Vellante, Federica Orsolini, Laura Fiengo, Annastasia Ventriglio, Antonio Yong-Ku, Kim Martinotti, Giovanni Di Giannantonio, Massimo Tomasetti, Carmine |
author_facet | De Berardis, Domenico Fornaro, Michele Valchera, Alessandro Cavuto, Marilde Perna, Giampaolo Di Nicola, Marco Serafini, Gianluca Carano, Alessandro Pompili, Maurizio Vellante, Federica Orsolini, Laura Fiengo, Annastasia Ventriglio, Antonio Yong-Ku, Kim Martinotti, Giovanni Di Giannantonio, Massimo Tomasetti, Carmine |
author_sort | De Berardis, Domenico |
collection | PubMed |
description | Despite the continuous advancement in neurosciences as well as in the knowledge of human behaviors pathophysiology, currently suicide represents a puzzling challenge. The World Health Organization (WHO) has established that one million people die by suicide every year, with the impressive daily rate of a suicide every 40 s. The weightiest concern about suicidal behavior is how difficult it is for healthcare professionals to predict. However, recent evidence in genomic studies has pointed out the essential role that genetics could play in influencing person’s suicide risk. Combining genomic and clinical risk assessment approaches, some studies have identified a number of biomarkers for suicidal ideation, which are involved in neural connectivity, neural activity, mood, as well as in immune and inflammatory response, such as the mammalian target of rapamycin (mTOR) signaling. This interesting discovery provides the neurobiological bases for the use of drugs that impact these specific signaling pathways in the treatment of suicidality, such as ketamine. Ketamine, an N-methyl-d-aspartate glutamate (NMDA) antagonist agent, has recently hit the headlines because of its rapid antidepressant and concurrent anti-suicidal action. Here we review the preclinical and clinical evidence that lay the foundations of the efficacy of ketamine in the treatment of suicidal ideation in mood disorders, thereby also approaching the essential question of the understanding of neurobiological processes of suicide and the potential therapeutics. |
format | Online Article Text |
id | pubmed-6213585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62135852018-11-14 Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors De Berardis, Domenico Fornaro, Michele Valchera, Alessandro Cavuto, Marilde Perna, Giampaolo Di Nicola, Marco Serafini, Gianluca Carano, Alessandro Pompili, Maurizio Vellante, Federica Orsolini, Laura Fiengo, Annastasia Ventriglio, Antonio Yong-Ku, Kim Martinotti, Giovanni Di Giannantonio, Massimo Tomasetti, Carmine Int J Mol Sci Review Despite the continuous advancement in neurosciences as well as in the knowledge of human behaviors pathophysiology, currently suicide represents a puzzling challenge. The World Health Organization (WHO) has established that one million people die by suicide every year, with the impressive daily rate of a suicide every 40 s. The weightiest concern about suicidal behavior is how difficult it is for healthcare professionals to predict. However, recent evidence in genomic studies has pointed out the essential role that genetics could play in influencing person’s suicide risk. Combining genomic and clinical risk assessment approaches, some studies have identified a number of biomarkers for suicidal ideation, which are involved in neural connectivity, neural activity, mood, as well as in immune and inflammatory response, such as the mammalian target of rapamycin (mTOR) signaling. This interesting discovery provides the neurobiological bases for the use of drugs that impact these specific signaling pathways in the treatment of suicidality, such as ketamine. Ketamine, an N-methyl-d-aspartate glutamate (NMDA) antagonist agent, has recently hit the headlines because of its rapid antidepressant and concurrent anti-suicidal action. Here we review the preclinical and clinical evidence that lay the foundations of the efficacy of ketamine in the treatment of suicidal ideation in mood disorders, thereby also approaching the essential question of the understanding of neurobiological processes of suicide and the potential therapeutics. MDPI 2018-09-23 /pmc/articles/PMC6213585/ /pubmed/30249029 http://dx.doi.org/10.3390/ijms19102888 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review De Berardis, Domenico Fornaro, Michele Valchera, Alessandro Cavuto, Marilde Perna, Giampaolo Di Nicola, Marco Serafini, Gianluca Carano, Alessandro Pompili, Maurizio Vellante, Federica Orsolini, Laura Fiengo, Annastasia Ventriglio, Antonio Yong-Ku, Kim Martinotti, Giovanni Di Giannantonio, Massimo Tomasetti, Carmine Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title_full | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title_fullStr | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title_full_unstemmed | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title_short | Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors |
title_sort | eradicating suicide at its roots: preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213585/ https://www.ncbi.nlm.nih.gov/pubmed/30249029 http://dx.doi.org/10.3390/ijms19102888 |
work_keys_str_mv | AT deberardisdomenico eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT fornaromichele eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT valcheraalessandro eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT cavutomarilde eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT pernagiampaolo eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT dinicolamarco eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT serafinigianluca eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT caranoalessandro eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT pompilimaurizio eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT vellantefederica eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT orsolinilaura eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT fiengoannastasia eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT ventriglioantonio eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT yongkukim eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT martinottigiovanni eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT digiannantoniomassimo eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors AT tomasetticarmine eradicatingsuicideatitsrootspreclinicalbasesandclinicalevidenceoftheefficacyofketamineinthetreatmentofsuicidalbehaviors |